Chemicals and Life Sciences Tracker
Transactions and Joint Ventures

Weekly Highlights:

17th December 2024

Eternis Fine Chemicals Acquires Sharon Personal Care

Eternis Fine Chemicals (Eternis) has successfully acquired Sharon Personal Care (Sharon PC), which has manufacturing capabilities in Italy and Israel and distribution sites in the US, Italy, Germany, and France. This acquisition marks Eternis’ further expansion of its portfolio and global distribution network in the growing personal care segment. 

Omya Acquires Distrupol from GPD Companies

Omya has entered into a definitive agreement to acquire Distrupol from GPD Companies, a leading global group of value-added distributors. Distrupol, a prominent European distributor of thermoplastics and elastomers, has expanded its presence significantly across the UK, Ireland, the Nordics, Benelux, and Egypt through strategic acquisitions over the past three years.

Eneos Acquires Full Ownership of ENEOS MOL Synthetic Rubber

ENEOS has signed an agreement to acquire MOL’s 49% stake in ENEOS MOL Synthetic Rubber (EMSR), resulting in full ownership of the company. The EMSR plant, operational since 2020 with a 60 ktpa capacity, was initially developed as part of a joint venture between MOL and JSR Corporation of Japan.

Styrenix to Acquire INEOS Styrolution’s Thailand Operations

Styrenix Performance Materials will acquire INEOS Styrolution’s 100% equity interest in its acrylonitrile butadiene styrene (ABS) and styrene acrylonitrile (SAN) production site in Thailand. The transaction aligns with INEOS Styrolution’s strategic focus on core styrenics operations and adds to their high-performing portfolio of styrene monomer, polystyrene, ABS, and advanced styrenic products. 

India Resurgence Fund Acquires a Majority Stake in Anthea Aromatics

India Resurgence Fund (IndiaRF) has invested INR 1,000 crores to acquire a controlling stake in Anthea Aromatics Private Limited. This marks IndiaRF’s second investment in the specialty chemicals sector and the first investment from its second fund, highlighting its focus on India-centric themes like domestic consumption and core manufacturing. 

Weekly Highlights:

10th December 2024

H.B. Fuller Acquires Medifill

H.B. Fuller has signed agreements to acquire Medifill, an Irish producer of medical-grade cyanoacrylate adhesives. This acquisition strengthens Fuller’s position in medical adhesive technologies, establishing a European headquarters and expanding its portfolio toward high-growth, high-profit markets. Combined, the acquisitions are expected to generate 2024 net revenue of €23 million and adjusted EBITDA of €11.5 million, with a purchase price of €180 million.

H.B. Fuller Acquires GEM S.r.l.

H.B. Fuller has agreed to acquire GEM, an Italian leader in medical adhesives and innovative application devices. This move enhances Fuller’s medical adhesive technologies business by leveraging GEM’s expertise in over 80 internal indications and builds upon prior investments in tissue adhesive markets, such as Cyberbond and Adhezion Biomedical. The acquisition supports Fuller’s strategy to diversify geographically and focus on next-generation solutions for wound closure and internal applications.

PPG Completes the Sale of Architectural Coatings U.S. and Canada Business to American Industrial Partners 

PPG has completed the sale of its architectural coatings business in the U.S. and Canada to American Industrial Partners for $550 million. This divestiture optimises PPG’s portfolio, allowing greater focus on its core operations in other regions and improving growth and financial return profiles through streamlined resources and strategic focus.

Roche Acquires Poseida Therapeutics

Roche has entered into a merger agreement to acquire Poseida Therapeutics for $9.00 per share in cash, with contingent payments of up to $4.00 per share upon meeting specific milestones, valuing the deal at $1.5 billion. The acquisition will bolster Roche’s expertise in allogeneic cell therapy, adding Poseida’s CAR-T programs for cancer and autoimmune diseases, as well as its innovative genetic engineering platform.

CBC Group Acquires UCB’s Mature Neurology and Allergy Business in China

CBC Group, in partnership with Mubadala, has acquired UCB’s neurology and allergy business in China, including its Zhuhai manufacturing site and brands like Xyzal and Keppra, for $680 million. The acquisition, which includes forming NeuroGen Pharma, aims to establish a CNS-focused biopharma platform and enhance healthcare services in China’s growing therapeutic market.

INEOS Sells INEOS Composites to KPS Capital Partners

INEOS has agreed to sell its composites business to KPS Capital Partners for approximately €1.7 billion, subject to regulatory approvals and consultations. The business, generating €800 million annually, operates across 17 sites globally and offers advanced resin solutions for diverse industrial applications.

Arkema Successfully Acquires Dow’s Flexible Packaging Laminating Adhesives Business

Arkema has finalised the acquisition of Dow’s flexible packaging laminating adhesives business, valued at $150 million, significantly expanding its portfolio in the packaging market. The acquisition, encompassing operations in North America and Europe, includes advanced production sites and will strengthen Arkema’s market presence in food and medical applications.

Sipcam Oxon Acquires Grosafe Chemicals

Sipcam Oxon has acquired Grosafe Chemicals, a New Zealand-based agrochemical company, enhancing its global presence in sustainable agriculture by integrating Grosafe’s local expertise with its operations. Additionally, its entry into Japan and innovations like N-Catch, featuring the nitrogen-fixing microbe Gluconacetobacter diazotrophicus, align with its mission to support on-farm profitability and sustainability.

Weekly Highlights:

3rd December 2024

Arlington Capital Partners Acquires TEAM Technologies

Arlington Capital Partners has acquired TEAM Technologies, a global manufacturer of essential healthcare products, from Clearlake Capital Group. TEAM provides outsourced design and manufacturing services to medical device and pharmaceutical OEMs, specialising in advanced medical devices critical to healthcare systems. The acquisition aligns with Arlington's strategy to strengthen healthcare supply chains and enhance TEAM’s solutions for medical and pharmaceutical clients.

Novartis Acquires Kate Therapeutics for $1.1B

Novartis has acquired Kate Therapeutics, a biotechnology company specialising in gene therapies for neuromuscular diseases, in a deal worth up to $1.1 billion. The acquisition strengthens Novartis’ gene therapy and neuroscience innovation capabilities, targeting unmet medical needs. 

ANSA McAL Acquires US-Based BleachTech LLC 

LBC Tank Terminals has acquired Evolution Terminals, advancing its energy transition strategy with plans for a renewable energy terminal in the port of Vlissingen in the Netherlands. This project will feature state-of-the-art ammonia storage and infrastructure, further positioning LBC as a leader in renewable energy logistics.

Arlington Capital Partners Acquires TEAM Technologies

Arlington Capital Partners has acquired TEAM Technologies, a global manufacturer of essential healthcare products, from Clearlake Capital Group. TEAM provides outsourced design and manufacturing services to medical device and pharmaceutical OEMs, specialising in advanced medical devices critical to healthcare systems. The acquisition aligns with Arlington's strategy to strengthen healthcare supply chains and enhance TEAM’s solutions for medical and pharmaceutical clients.

Novartis Acquires Kate Therapeutics for $1.1B

Novartis has acquired Kate Therapeutics, a biotechnology company specialising in gene therapies for neuromuscular diseases, in a deal worth up to $1.1 billion. The acquisition strengthens Novartis’ gene therapy and neuroscience innovation capabilities, targeting unmet medical needs. 

ANSA McAL Acquires US-Based BleachTech LLC 

LBC Tank Terminals has acquired Evolution Terminals, advancing its energy transition strategy with plans for a renewable energy terminal in the port of Vlissingen in the Netherlands. This project will feature state-of-the-art ammonia storage and infrastructure, further positioning LBC as a leader in renewable energy logistics.

Aon to Acquire Mitsubishi Chemical’s In-House Insurance Agency 

Aon has entered into a definitive agreement to acquire the in-house insurance agency business of Mitsubishi Chemical Group (MCG), enhancing its risk and health capabilities in Japan. The divestiture enables MCG to focus resources and investments on its core operations while benefiting from Aon's global risk management expertise to enhance its governance.

Adragos Pharma Successfully Acquires Swiss CDMO Baccinex

Adragos Pharma has acquired Baccinex, a Swiss CDMO specialising in aseptic fill-finish and lyophilization, significantly enhancing its sterile manufacturing capabilities. This acquisition, which adds a sixth global site to Adragos’ network, strengthens its position as a global partner of choice for high-quality pharmaceutical manufacturing. 

Safic-Alcan Acquires Majority Stake in Avees Biocos

Safic-Alcan has acquired a majority stake in Avees Biocos, an Indian distributor of personal care chemicals, as part of its strategy to expand in the Asia Pacific region. This partnership builds on their existing relationship and enhances Safic-Alcan’s global personal care footprint, leveraging Avees Biocos’ expertise and innovation centre in Gurugram.

Weekly Highlights:

26th November 2024

ICIG and Vynova Group Acquires the European Advanced Organics Business from Valtris Specialty Chemicals

ICIG and Vynova Group have acquired the European advanced organics business from Valtris Specialty Chemicals, including production plants in Belgium and the Netherlands. This strategic acquisition integrates the advanced organics business into Vynova Group, enhancing its portfolio with key chemical intermediates used in a large number of markets such as coatings, flavour & fragrance, personal care, agrochemicals, and pharmaceutical applications. 

Sun A. Kaken Acquires Resonac’s Surface Protection Film Business

Sun A. Kaken has completed the acquisition of Resonac Corporation’s surface protection film business. This transaction aligns with Resonac’s long-term vision to optimise its business portfolio, ensuring sustainable growth while leveraging Sun A. Kaken’s expertise in plastic film processing.

ANSA McAL Acquires US-Based BleachTech LLC 

ANSA McAL has acquired chlor-alkali producer BleachTech LLC for $327 million, marking the Caribbean conglomerate’s largest acquisition in its history. This move expands ANSA McAL’s market reach into North America, complementing its leadership in the Caribbean chemical industry and enhancing its focus on sustainable water treatment solutions.

Azelis Acquires Haarla Oy

Azelis has announced the acquisition of Haarla Oy, a Finland-based distributor of food ingredients and industrial chemicals, marking a strategic move to enhance its portfolio in the Nordics. Haarla Oy's strong presence in food ingredients, its 300+ customer base, and longstanding principal relationships align well with Azelis’ growth strategy and product portfolio in life sciences and industrial chemicals.

Sayona Mining Merges with US-based Piedmont Lithium 

Sayona Mining and Piedmont Lithium have announced their merger as a 50/50 all-stock transaction to create a leading North American hard rock lithium producer. The merger aims to unlock synergies, simplify corporate structures, and strengthen the balance sheet, with equity financing planned to support significant expansion opportunities.

Amcor Acquires Berry Global for $8.4 Billion 

Amcor has agreed to acquire Berry Global in an all-stock transaction valued at $8.4 billion, combining their operations to create a global leader in consumer packaging solutions. This acquisition is expected to generate $24 billion in revenue and $4.3 billion in adjusted EBITDA while driving synergies through innovation, sustainability initiatives, and increased investment in R&D.

Symrise Offers to Acquire Probi

Symrise has announced a public offer to acquire all outstanding shares of Probi, a biotics solutions company listed on Nasdaq Stockholm. As Probi's largest shareholder since 2012, Symrise aims to integrate Probi into its health-focused strategy, leveraging its expertise to drive global growth in probiotics for functional foods and supplements.

Weekly Highlights:

18th November 2024

Maravai LifeSciences to Acquire Officinae Bio’s DNA and RNA Business

Maravai LifeSciences has announced the acquisition of Officinae Bio’s DNA and RNA business to enhance its nucleic acid-based therapy offerings. This acquisition complements Maravai’s expertise in nucleic acid production with Officinae Bio’s proprietary digital platform for rapid prototyping of mRNA candidates, expanding customer capabilities in therapeutic innovation.

Nippon Shokubai Acquires Emulsion Technology from JSR Corporation 

Nippon Shokubai has acquired JSR Corporation's emulsion business under the name E-TECH, marking a strategic expansion into construction chemicals. The acquisition leverages E-TECH’s expertise in adhesives and waterproofing polymers, aligning with Nippon Shokubai's industrial and household business growth.

SMC Global Acquires International Chemicals LLC

SMC Global has acquired International Chemicals LLC (ICC), integrating its oilfield business with ICC’s operations to enhance capabilities in oil and gas solutions. The merger includes a trucking fleet and ICC’s facilities in Texas, enabling efficient manufacturing and customer service.

Indorama Ventures Acquires Cargill’s KEMELIX and FLOWSOLVE brands

Indorama Ventures, through its Indovinya subsidiary, has acquired Cargill’s KEMELIX and FLOWSOLVE brands to expand its specialty surfactant portfolio. These brands strengthen Indorama’s offerings in demulsifiers and flow assurance products, critical for operational efficiency in energy extraction sectors.

Imerys Divests Paper Market Assets to Flacks Group 

Imerys, a leading global supplier of mineral-based specialty solutions, has completed the sale of its paper market assets to an affiliate of Flacks Group for approximately €150 million. This divestiture allows Imerys to focus on its growth strategy in specialty mineral solutions, particularly in energy transition, sustainable construction, and natural solutions for consumer goods.